Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer
Author:
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
https://link.springer.com/content/pdf/10.1245/s10434-022-11975-6.pdf
Reference38 articles.
1. Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97(13):966–75. https://doi.org/10.1093/jnci/dji172.
2. Koch RM, Principe DR, Cataneo JL, Rana A. Progress for immunotherapy in inflammatory breast cancer and emerging barriers to therapeutic efficacy. Cancers (Basel). 2021. https://doi.org/10.3390/cancers13112543.
3. Brzezinska M, Dixon JM. Inflammatory breast cancer: no longer an absolute contraindication for breast conservation surgery following good response to neoadjuvant therapy. Gland Surg. 2018;7(6):520–4. https://doi.org/10.21037/gs.2018.08.04.
4. Walshe JM, Swain SM. Clinical aspects of inflammatory breast cancer. Breast Dis. 2005;22:35–44. https://doi.org/10.3233/bd-2006-22105.
5. Rueth NM, Lin HY, Bedrosian I, et al. Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database. J Clin Oncol. 2014;32(19):2018–24. https://doi.org/10.1200/jco.2014.55.1978.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions;Current Oncology Reports;2024-04-23
2. The Role of Primary Surgery in De Novo Metastatic Breast Carcinoma;European Journal of Breast Health;2023-04-01
3. Sobrevida global e fatores associados em mulheres com câncer de mama metastático tratadas com trastuzumabe em uma instituição pública de referência;Revista Brasileira de Epidemiologia;2023
4. Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution;Revista Brasileira de Epidemiologia;2023
5. Current Status of Diagnosis and Management of Inflammatory Breast Cancer;Advances in Clinical Medicine;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3